54 related articles for article (PubMed ID: 9257875)
1. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Am J Hematol; 1997 Aug; 55(4):169-74. PubMed ID: 9257875
[TBL] [Abstract][Full Text] [Related]
2. Microparticle-associated tissue factor activity correlates with the inflammatory response in septic disseminated intravascular coagulation patients.
Meng S; Xu B; Yang W; Zhao M
PeerJ; 2024; 12():e16636. PubMed ID: 38213768
[TBL] [Abstract][Full Text] [Related]
3. A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI).
Dahm AE; Andersen TO; Rosendaal F; Sandset PM
J Thromb Haemost; 2005 Apr; 3(4):651-8. PubMed ID: 15842349
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of pig tissue factor pathway inhibitor α to increase anti-coagulation activity in pig-to-human xenotransplantation.
Lee CH; Lee HJ; Park SW; Shin J; Kang SJ; Park IB; Kim HK; Chun T
Biotechnol Lett; 2024 Jun; ():. PubMed ID: 38872071
[TBL] [Abstract][Full Text] [Related]
5. Circulating Syndecan-1 and Tissue Factor Pathway Inhibitor, Biomarkers of Endothelial Dysfunction, Predict Mortality in Burn Patients.
Keyloun JW; Le TD; Pusateri AE; Ball RL; Carney BC; Orfeo T; Brummel-Ziedins KE; Bravo MC; McLawhorn MM; Moffatt LT; Shupp JW;
Shock; 2021 Aug; 56(2):237-244. PubMed ID: 33394974
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor pathway inhibitor in paediatric patients with nephrotic syndrome.
Farid FA; Mohammed AA; Afifi HM; Beltagi RS
SAJCH; 2011 Dec; 5(4):107-111. PubMed ID: 22319062
[TBL] [Abstract][Full Text] [Related]
7. Plasma tissue factor pathway inhibitor levels in coronavirus disease 2019 patients: a systematic review and meta-analysis.
Hassani S; Sayyadi M; Almasi-Hashiani A
Blood Coagul Fibrinolysis; 2024 Jun; 35(4):196-205. PubMed ID: 38625831
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the ability of commercial enzyme-linked immunosorbent assays to measure mouse tissue factor.
Sachetto ATA; Mackman N
Res Pract Thromb Haemost; 2024 Jan; 8(1):102325. PubMed ID: 38404939
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of four commercial ELISAs to measure tissue factor in human plasma.
Sachetto ATA; Archibald SJ; Bhatia R; Monroe D; Hisada Y; Mackman N
Res Pract Thromb Haemost; 2023 Mar; 7(3):100133. PubMed ID: 37275179
[TBL] [Abstract][Full Text] [Related]
10. Proteomic profile of extracellular vesicles in maternal plasma of women with fetal death.
Gallo DM; Fitzgerald W; Romero R; Gomez-Lopez N; Gudicha DW; Than NG; Bosco M; Chaiworapongsa T; Jung E; Meyyazhagan A; Suksai M; Gotsch F; Erez O; Tarca AL; Margolis L
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2177529. PubMed ID: 36813269
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in pathophysiology of disseminated intravascular coagulation: the role of circulating histones and neutrophil extracellular traps.
Alhamdi Y; Toh CH
F1000Res; 2017; 6():2143. PubMed ID: 29399324
[TBL] [Abstract][Full Text] [Related]
12. Disseminated intravascular coagulation.
Venugopal A
Indian J Anaesth; 2014 Sep; 58(5):603-8. PubMed ID: 25535423
[TBL] [Abstract][Full Text] [Related]
13. Placental vascular pathology and increased thrombin generation as mechanisms of disease in obstetrical syndromes.
Mastrolia SA; Mazor M; Loverro G; Klaitman V; Erez O
PeerJ; 2014; 2():e653. PubMed ID: 25426334
[TBL] [Abstract][Full Text] [Related]
14. Bothrops jararaca venom metalloproteinases are essential for coagulopathy and increase plasma tissue factor levels during envenomation.
Yamashita KM; Alves AF; Barbaro KC; Santoro ML
PLoS Negl Trop Dis; 2014 May; 8(5):e2814. PubMed ID: 24831016
[TBL] [Abstract][Full Text] [Related]
15. Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis.
Kambas K; Mitroulis I; Apostolidou E; Girod A; Chrysanthopoulou A; Pneumatikos I; Skendros P; Kourtzelis I; Koffa M; Kotsianidis I; Ritis K
PLoS One; 2012; 7(9):e45427. PubMed ID: 23029002
[TBL] [Abstract][Full Text] [Related]
16. High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor.
Erez O; Romero R; Vaisbuch E; Kusanovic JP; Mazaki-Tovi S; Chaiworapongsa T; Gotsch F; Fareed J; Hoppensteadt D; Than NG; Yoon BH; Edwin S; Dong Z; Espinoza J; Mazor M; Hassan SS
J Matern Fetal Neonatal Med; 2010 Jan; 23(1):23-33. PubMed ID: 19883261
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor and its natural inhibitor in pre-eclampsia and SGA.
Erez O; Romero R; Hoppensteadt D; Than NG; Fareed J; Mazaki-Tovi S; Espinoza J; Chaiworapongsa T; Kim SS; Yoon BH; Hassan SS; Gotsch F; Friel L; Vaisbuch E; Kusanovic JP
J Matern Fetal Neonatal Med; 2008 Dec; 21(12):855-69. PubMed ID: 19065458
[TBL] [Abstract][Full Text] [Related]
18. A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor.
Erez O; Espinoza J; Chaiworapongsa T; Gotsch F; Kusanovic JP; Than NG; Mazaki-Tovi S; Vaisbuch E; Papp Z; Yoon BH; Han YM; Hoppensteadt D; Fareed J; Hassan SS; Romero R
J Matern Fetal Neonatal Med; 2008 Oct; 21(10):732-44. PubMed ID: 19012190
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of overt disseminated intravascular coagulation: a comparative study using criteria from the International Society versus the Korean Society on Thrombosis and Hemostasis.
Lee JH; Song JW; Song KS
Yonsei Med J; 2007 Aug; 48(4):595-600. PubMed ID: 17722230
[TBL] [Abstract][Full Text] [Related]
20. Emerging therapies in severe sepsis.
Finney SJ; Evans TW
Thorax; 2002 Oct; 57 Suppl 2(Suppl 2):II8-II14. PubMed ID: 12364705
[No Abstract] [Full Text] [Related]
[Next] [New Search]
